The Wall Street Journal traces how suppliers tied to fentanyl precursors have moved into selling gray-market peptides to American buyers.
Recap by typeshit. Full story at WSJ.
The non-binding vote went against the FDA's own scientists, who opposed every peptide. Six of the eight new panel members run clinics that offer peptides.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
A look at how the rise of GLP-1 drugs is changing which research samples scientists are buying. Details are thin beyond the headline.
Grocery Dive reports the supermarket chain is adding guided store tours built for shoppers taking GLP-1 medications.
Loading…